'Moonshot' Opportunities: Dx Reimbursement, Radiation Therapy Among Medtech Focal Points
This article was originally published in The Gray Sheet
Personalized-medicine advocates say Vice President Biden's "Cancer Moonshot" initiative is a great opportunity, but it should be putting more focus on the importance of Medicare policies in driving cancer innovation. There is also a push in the medtech space to raise the profile of radiation therapy as a central tool for treating cancer.
You may also be interested in...
US House Would Boost NIH Spending By $2Bn, Support Precision Medicine, BRAIN Initiative, Cybersecurity Funds
The US National Institutes of Health would get a 5% raise of $2bn under a 2020 budget increase to $41.1bn, spending that would go to boost precision medicine research, the BRAIN Initiative, Cancer Moonshot, cybersecurity and other important programs.
In line with the 21st Century Cures Act, US FDA has finalized a list of class II devices that will no longer need pre-market notification to get to market. Also, check out our updated Cures Act implementation table.
Dozens of reforms impacting the medtech sector were signed into law Dec. 13, 2016, in the 21st Century Cures Act. Here's a breakdown of where things stand in the implementation of key provisions.